UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future

Drugs (New York, N.Y.), 2024-09, Vol.84 (9), p.1035-1053

2024

Volltextzugriff (PDF)

Cyclodestructive procedures for refractory glaucoma

Cochrane database of systematic reviews, 2019-03, Vol.3 (3), p.CD012223-CD012223

2019

Volltextzugriff (PDF)

Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced ALK- or ROS1-Rearranged NSCLC: A Brief Report

JTO clinical and research reports, 2023-08, Vol.4 (8), p.100546, Article 100546

2023

Volltextzugriff (PDF)

Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to "False" Decreases in Renal Function

Journal of thoracic oncology, 2024-01, Vol.19 (1), p.153-159

2024

Volltextzugriff (PDF)

Early-stage anaplastic lymphoma kinase (ALK)-positive lung cancer: a narrative review

Translational lung cancer research, 2023-02, Vol.12 (2), p.337-345

2023

Volltextzugriff (PDF)

Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure

Cochrane database of systematic reviews, 2017-02, Vol.2 (2), p.CD012131

2017

Volltextzugriff (PDF)

Superior sulcus non-small cell lung cancers (Pancoast tumors): Current outcomes after multidisciplinary management

The Journal of thoracic and cardiovascular surgery, 2023-12, Vol.166 (6), p.1477-1487.e8

2023

Volltextzugriff (PDF)

Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets

Clinical cancer research, 2024-09, Vol.30 (17), p.3812-3823

2024

Volltextzugriff (PDF)

Adaptive optics imaging of healthy and abnormal regions of retinal nerve fiber bundles of patients with glaucoma

Investigative ophthalmology & visual science, 2015-01, Vol.56 (1), p.674-681

2015

Volltextzugriff (PDF)

Etiology and Age Modifies Subjective Visual Function After Cerebral Hemispherectomy

Journal of child neurology, 2019-07, Vol.34 (8), p.446-451

2019

Volltextzugriff (PDF)

Long-Term Patient-Reported Outcomes of Visual Field Defects and Compensatory Mechanisms in Patients After Cerebral Hemispherectomy

Journal of neuro-ophthalmology, 2021-06, Vol.41 (2), p.147-153

2021

Volltextzugriff (PDF)

Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors

Cancer discovery, 2024-08, Vol.14 (8), p.1440-1456

2024

Volltextzugriff (PDF)

Response to Repotrectinib After Development of NTRK Resistance Mutations on First- and Second-Generation TRK Inhibitors

JCO precision oncology, 2023-05, Vol.7 (7), p.e2200697

2023

Volltextzugriff (PDF)

Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E

JCO precision oncology, 2024-04, Vol.8 (8), p.e2300454

2024

Volltextzugriff (PDF)

Confocal Adaptive Optics Imaging of Peripapillary Nerve Fiber Bundles: Implications for Glaucomatous Damage Seen on Circumpapillary OCT Scans

Translational vision science & technology, 2015-04, Vol.4 (2), p.12-12

2015

Volltextzugriff (PDF)

Predictors of benefit to radiation for oligoprogressive disease in EGFR -mutant metastatic non-small cell lung cancer patients treated with osimertinib

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21127-e21127

2023

Volltextzugriff (PDF)

Early-stage ALK-positive lung cancer: a narrative review

Translational lung cancer research, 2023-02, Vol.12 (2), p.337-345

2023

Volltextzugriff (PDF)

Abstract P2-10-07: Cardiovascular disease risk and statin use among women with breast cancer treated with adjuvant aromatase inhibitor therapy

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-10-07

2020

Volltextzugriff (PDF)

Elevated Creatinine With Selpercatinib Therapy in RET-Dependent Malignancies: SA-PO117

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.632-632

2022

Volltextzugriff (PDF)

Abstract S11-02: Factors associated with developing COVID-19 among cancer patients in New York City

Clinical cancer research, 2021-03, Vol.27 (6_Supplement), p.S11-S11-02

2021

Volltextzugriff (PDF)

Trastuzumab-induced cardiotoxicity and hypertension among racially and ethnically diverse patients with HER2-positive early-stage breast cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e24092-e24092

2020

Volltextzugriff (PDF)

Osimertinib, platinum, etoposide as initial treatment for patients with EGFR mutant lung cancers with TP53 and RB1 alterations

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8565-8565

2024

Volltextzugriff (PDF)

Standardizing radiologic reporting of response to improve the patient experience: Comparing response categories of RECIST 1.1 and a novel, real-world, standardized, oncologic response lexicon derived from clinical radiology reports

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13810-e13810

2024

Volltextzugriff (PDF)

A phase 2 study of amivantamab plus lazertinib in patients with EGFR- mutant lung cancer and active central nervous system disease

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8517-8517

2024

Volltextzugriff (PDF)

MYC amplification segment-size mutual exclusivity analysis with other oncogenic events in a pan-cancer sequencing cohort

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3073-3073

2023

Volltextzugriff (PDF)

1 – 25 von 330

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(312)
Mit Volltextzugriff
(284)

Publikationsform

Sprache

Englisch
(329)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future

Cyclodestructive procedures for refractory glaucoma

Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced ALK- or ROS1-Rearranged NSCLC: A Brief Report

Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to "False" Decreases in Renal Function

Early-stage anaplastic lymphoma kinase (ALK)-positive lung cancer: a narrative review

Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure

Superior sulcus non-small cell lung cancers (Pancoast tumors): Current outcomes after multidisciplinary management

Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets

Adaptive optics imaging of healthy and abnormal regions of retinal nerve fiber bundles of patients with glaucoma

Etiology and Age Modifies Subjective Visual Function After Cerebral Hemispherectomy

Long-Term Patient-Reported Outcomes of Visual Field Defects and Compensatory Mechanisms in Patients After Cerebral Hemispherectomy

Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors

Response to Repotrectinib After Development of NTRK Resistance Mutations on First- and Second-Generation TRK Inhibitors

Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E

Confocal Adaptive Optics Imaging of Peripapillary Nerve Fiber Bundles: Implications for Glaucomatous Damage Seen on Circumpapillary OCT Scans

Predictors of benefit to radiation for oligoprogressive disease in EGFR -mutant metastatic non-small cell lung cancer patients treated with osimertinib

Early-stage ALK-positive lung cancer: a narrative review

Abstract P2-10-07: Cardiovascular disease risk and statin use among women with breast cancer treated with adjuvant aromatase inhibitor therapy

Elevated Creatinine With Selpercatinib Therapy in RET-Dependent Malignancies: SA-PO117

Abstract S11-02: Factors associated with developing COVID-19 among cancer patients in New York City

Trastuzumab-induced cardiotoxicity and hypertension among racially and ethnically diverse patients with HER2-positive early-stage breast cancer

Osimertinib, platinum, etoposide as initial treatment for patients with EGFR mutant lung cancers with TP53 and RB1 alterations

Standardizing radiologic reporting of response to improve the patient experience: Comparing response categories of RECIST 1.1 and a novel, real-world, standardized, oncologic response lexicon derived from clinical radiology reports

A phase 2 study of amivantamab plus lazertinib in patients with EGFR- mutant lung cancer and active central nervous system disease

MYC amplification segment-size mutual exclusivity analysis with other oncogenic events in a pan-cancer sequencing cohort

Suchergebnisse filtern